J A Hobden

1.0k total citations
26 papers, 829 citations indexed

About

J A Hobden is a scholar working on Ophthalmology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, J A Hobden has authored 26 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Ophthalmology, 9 papers in Molecular Biology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in J A Hobden's work include Ocular Infections and Treatments (12 papers), Bacterial biofilms and quorum sensing (8 papers) and Antibiotic Resistance in Bacteria (5 papers). J A Hobden is often cited by papers focused on Ocular Infections and Treatments (12 papers), Bacterial biofilms and quorum sensing (8 papers) and Antibiotic Resistance in Bacteria (5 papers). J A Hobden collaborates with scholars based in United States, Saudi Arabia and Australia. J A Hobden's co-authors include Richard J. O’Callaghan, James M. Hill, Lawrence S. Engel, Linda D. Hazlett, Michelle C. Callegan, S. Masinick, Brigitte A. Cowell, Ronald P. Barrett, Judy M. Moreau and Suzanne M. J. Fleiszig and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Infection and Immunity and Journal of Antimicrobial Chemotherapy.

In The Last Decade

J A Hobden

26 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J A Hobden United States	17	375	340	199	198	120	26	829
M J Preston United States	15	668 1.8×	234 0.7×	187 0.9×	307 1.6×	145 1.2×	19	1.1k
Jeffery A. Hobden United States	20	209 0.6×	447 1.3×	212 1.1×	68 0.3×	182 1.5×	29	829
Susan R. Heimer United States	10	236 0.6×	122 0.4×	148 0.7×	62 0.3×	109 0.9×	15	576
Melissa Hamilton United States	9	295 0.8×	58 0.2×	30 0.2×	72 0.4×	93 0.8×	18	534
Roger Astley United States	18	230 0.6×	346 1.0×	115 0.6×	39 0.2×	172 1.4×	33	690
Chairut Vareechon United States	10	162 0.4×	98 0.3×	80 0.4×	40 0.2×	171 1.4×	15	574
Mahmood Ghassemi United States	14	313 0.8×	29 0.1×	82 0.4×	36 0.2×	144 1.2×	36	821
Andreas Obwaller Austria	15	425 1.1×	168 0.5×	111 0.6×	27 0.1×	98 0.8×	26	1.0k
Clyde Schultz Canada	14	96 0.3×	190 0.6×	337 1.7×	13 0.1×	133 1.1×	35	705
Seong Hoong Chow Australia	12	324 0.9×	15 0.0×	59 0.3×	80 0.4×	101 0.8×	17	581

Countries citing papers authored by J A Hobden

Since Specialization

Citations

This map shows the geographic impact of J A Hobden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J A Hobden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J A Hobden more than expected).

Fields of papers citing papers by J A Hobden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J A Hobden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J A Hobden. The network helps show where J A Hobden may publish in the future.

Co-authorship network of co-authors of J A Hobden

This figure shows the co-authorship network connecting the top 25 collaborators of J A Hobden. A scholar is included among the top collaborators of J A Hobden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J A Hobden. J A Hobden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cole, Marsha, Meng Li, Ravirajsinh N. Jadeja, et al.. (2013). Minimizing human infection from Escherichia coli O157:H7 using GUMBOS. Journal of Antimicrobial Chemotherapy. 68(6). 1312–1318. 14 indexed citations

Hobden, J A, et al.. (2007). Surfactant Protein D inPseudomonas aeruginosaKeratitis. Ocular Immunology and Inflammation. 15(5). 371–379. 14 indexed citations

Hobden, J A. (2003). Intercellular Adhesion Molecule-2 (ICAM-2) and Pseudomonas aeruginosa Ocular Infection. DNA and Cell Biology. 22(10). 649–655. 7 indexed citations

Caballero, Armando R., et al.. (2001). Corneal Virulence of LasA Protease-deficient Pseudomonas aeruginosa PAO1. Cornea. 20(6). 643–646. 11 indexed citations

Caballero, Armando R., et al.. (2001). Pseudomonas aeruginosa LasA protease and corneal infections. Current Eye Research. 22(4). 266–271. 17 indexed citations

Pillar, Chris M., Linda D. Hazlett, & J A Hobden. (2000). Alkaline protease-deficient mutants of Pseudomonas aeruginosa are virulent in the eye. Current Eye Research. 21(3). 730–739. 15 indexed citations

Engel, Lawrence S., et al.. (1998). Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence.. PubMed. 39(3). 662–5. 75 indexed citations

Cowell, Brigitte A., Mark Willcox, J A Hobden, et al.. (1998). An Ocular Strain ofPseudomonas aeruginosais Inflammatory but not Virulent in the Scarified Mouse Model. Experimental Eye Research. 67(3). 347–356. 30 indexed citations

Hobden, J A, S. Masinick, Ronald P. Barrett, & L.D. Hazlett. (1997). Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice. Infection and Immunity. 65(7). 2754–2758. 52 indexed citations

10.

Gupta, Suresh, S. Masinick, J A Hobden, R. S. Berk, & Linda D. Hazlett. (1996). Bacterial Proteases and Adherence ofPseudomonas aeruginosato Mouse Cornea. Experimental Eye Research. 62(6). 641–650. 24 indexed citations

11.

O’Callaghan, Richard J., et al.. (1996). Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence.. PubMed. 37(4). 534–43. 100 indexed citations

12.

Kernacki, Karen A., J A Hobden, Linda D. Hazlett, Rafael Fridman, & R. S. Berk. (1995). In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection.. PubMed. 36(7). 1371–8. 68 indexed citations

13.

Hobden, J A, S. Masinick, Ronald P. Barrett, & Linda D. Hazlett. (1995). Aged mice fail to upregulate ICAM-1 after Pseudomonas aeruginosa corneal infection.. PubMed. 36(6). 1107–14. 35 indexed citations

14.

Johnson, Mary K., Michelle C. Callegan, Lawrence S. Engel, et al.. (1995). Growth and virulence of a complement-activation-negative mutant ofStreptococcus pneumoniaein the rabbit cornea. Current Eye Research. 14(4). 281–284. 17 indexed citations

15.

Hill, James M., et al.. (1993). Ocular Antivirals. International Ophthalmology Clinics. 33(4). 69–80. 2 indexed citations

16.

Callegan, Michelle C., J A Hobden, James M. Hill, Michael S. Insler, & Richard J. O’Callaghan. (1992). Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.. PubMed. 33(11). 3017–23. 44 indexed citations

17.

Hobden, J A, James J. Reidy, Richard J. O’Callaghan, Michael S. Insler, & James M. Hill. (1990). Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis.. PubMed. 31(11). 2241–3. 16 indexed citations

18.

Hobden, J A. (1988). Treatment of Experimental Pseudomonas Keratitis Using Collagen Shields Containing Tobramycin. Archives of Ophthalmology. 106(11). 1605–1605. 33 indexed citations

19.

Rootman, David S., et al.. (1988). Iontophoresis of Tobramycin for the Treatment of Experimental Pseudomonas Keratitis in the Rabbit. Archives of Ophthalmology. 106(2). 262–265. 40 indexed citations

20.

Hobden, J A, David S. Rootman, Richard J. O’Callaghan, & James M. Hill. (1988). Iontophoretic application of tobramycin to uninfected and Pseudomonas aeruginosa-infected rabbit corneas. Antimicrobial Agents and Chemotherapy. 32(7). 978–981. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact